Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours Β· Estimated delivery Aug 18 - Aug 23
In humans it is a 29 amino acid peptide with an amidated carboxyl terminal
Presented for research literature review only Lanciotti M et al
Notably, GHKCu is a tool for exploring copper-dependent signaling and tissue regulation, with effects observed only in specific research models
TB-500 protocol considerations Reported dosing in the research literature: Starting dose: 500 mcg daily, subcutaneous injection Titration: Increase by 100 to 150 mcg every two weeks as tolerated Target dose: 750 to 1000 mcg daily by weeks five through twelve Weekly total: Approximately 5 mg per week at full dose Cycle length: Eight to twelve weeks, with optional extension to sixteen weeks TB-500 is typically administered once daily via subcutaneous injection, with consistent timing and systematic site rotation
Even when looking at the aforementioned Swedish study, using hospitalization to determine the drugs effects on alcohol use disorder is also considered an imperfect measure
Baseline Skin Tone Results vary based on your starting point
